Dave st. Jean

Dave St. Jean is a seasoned pharmaceutical professional with extensive experience in medicinal chemistry and drug discovery. Currently serving as the Senior Vice President of Chemistry and Head of Late Discovery at Odyssey Therapeutics since August 2024, Dave previously held the position of Vice President of Chemistry at Scorpion Therapeutics from July 2020 to August 2024. Prior to that role, Dave worked as the Sr. Director of Neuroscience/Pain - Chemistry at Grünenthal Group and spent 15 years at Amgen in various capacities, culminating in the role of Director of Medicinal Chemistry. Dave holds a Ph.D. in Organic Chemistry from the University of Pennsylvania and a BA in Chemistry from Goucher College.